Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
Disease Category: Thrombosis
Location: United States, ND
Prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy
To compare the efficacy of once daily injections in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 163091
Date Last Changed:
July 24, 2013
Dr. Tom Davis, Director of Business DevelopmentLegacy Pharma Research601 N. 5th St.Bismarck, ND 58501Phone: 701-751-1128Fax: 701-751-1131
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.